Gerald Quirk
General Counsel en SYROS PHARMACEUTICALS, INC. .
Fortuna: 212 700 $ al 31/03/2024
Perfil
Gerald E.
Quirk is currently the Chief Legal Officer at Syros Pharmaceuticals, Inc. He previously worked as Co-Chairman-Life Sciences Group at Choate, Hall & Stewart LLP, Managing Corporate Counsel at Genzyme Corp., Secretary, VP-Corporate Affairs & General Counsel at Infinity Pharmaceuticals, Inc., and Executive VP-Business Operations & General Counsel at Tokai Pharmaceuticals, Inc. He also worked as an Associate-Business Law Department at Palmer & Dodge LLP.
Quirk received his undergraduate degree from Swarthmore College and his graduate degrees from Harvard University and Northeastern University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/03/2024 | 39 757 ( 0.15% ) | 212 700 $ | 31/03/2024 |
Cargos activos de Gerald Quirk
| Empresas | Cargo | Inicio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | General Counsel | - |
Antiguos cargos conocidos de Gerald Quirk.
| Empresas | Cargo | Fin |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Administrative Officer | 01/03/2022 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | General Counsel | 31/08/2016 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/05/2015 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 01/08/2012 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2006 |
Formación de Gerald Quirk.
| Harvard University | Graduate Degree |
| Swarthmore College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Gerald Quirk
